Japan holds a significant 28% share of the insulin pen market in the Asia-Pacific, with the market projected to grow at a 3% compound annual rate until 2033. This growth is driven by the healthcare sector's increasing use of insulin pens, valued for their precision and ease of use in addressing diabetes. However, this expansion raises environmental concerns due to the pens' contribution to biomedical waste.
Aditi Dakshesh Parikh of GlobalData emphasizes the need to move beyond waste management to ensure environmental sustainability in healthcare. Approximately 77% of insulin pens in Japan are made of plastic, further exacerbating environmental issues. Parikh underscores the importance of adopting sustainable practices in diabetes management, given the intersection of healthcare needs, environmental concerns, and technological advancements.
Aditi Parikh#Globaldata#Healthcare#InsulinPens#Japan#MedicalDevice#MarketGrowth#Asia#Diabetes